# FutureFuel Corp.: overview FF · NYSE · CIK 1337298 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ff.md) · [Financials](/companies/ff/financials.md) · [Filings](/companies/ff/filings.md) · [Insiders](/companies/ff/insiders.md) Latest reported revenue: [$78.7m](/filings/0001437749-26-026784.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-026784). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [51.1](/filings/0001437749-25-034102.md) | [61.5 d](/filings/0001437749-26-008411.md) | [17.5](/filings/0001437749-26-016116.md) | [35.7](/filings/0001437749-26-026784.md) | [22.7](/filings/0001437749-25-034102.md) | [19.8 d](/filings/0001437749-26-008411.md) | [32.0](/filings/0001437749-26-016116.md) | [78.7](/filings/0001437749-26-026784.md) | | Gross margin | % | [0.7%](/filings/0001437749-25-034102.md) | [9.1% d](/filings/0001437749-26-008411.md) | [(86.6%)](/filings/0001437749-26-016116.md) | [(34.7%)](/filings/0001437749-26-026784.md) | [(30.1%)](/filings/0001437749-25-034102.md) | [(46.7%) d](/filings/0001437749-26-008411.md) | [(49.6%)](/filings/0001437749-26-016116.md) | [19.1%](/filings/0001437749-26-026784.md) | | Operating margin | % | [(5.6%)](/filings/0001437749-25-034102.md) | [2.6% d](/filings/0001437749-26-008411.md) | [(111.0%)](/filings/0001437749-26-016116.md) | [(43.6%)](/filings/0001437749-26-026784.md) | [(42.9%)](/filings/0001437749-25-034102.md) | [(62.9%) d](/filings/0001437749-26-008411.md) | [(65.2%)](/filings/0001437749-26-016116.md) | [14.3%](/filings/0001437749-26-026784.md) | | Net margin | % | [(2.3%)](/filings/0001437749-25-034102.md) | [4.5% d](/filings/0001437749-26-008411.md) | [(103.2%)](/filings/0001437749-26-026784.md) | [(39.8%)](/filings/0001437749-26-026784.md) | [(41.1%)](/filings/0001437749-25-034102.md) | [(60.5%) d](/filings/0001437749-26-008411.md) | [(64.4%)](/filings/0001437749-26-026784.md) | [14.4%](/filings/0001437749-26-026784.md) | | Diluted EPS | $ per share | [(0.03)](/filings/0001437749-25-034102.md) | not reported | [(0.41)](/filings/0001437749-26-016116.md) | [(0.32)](/filings/0001437749-26-026784.md) | [(0.21)](/filings/0001437749-25-034102.md) | not reported | [(0.47)](/filings/0001437749-26-016116.md) | [0.25](/filings/0001437749-26-026784.md) | | Free cash flow | $m | [20.5 d](/filings/0001437749-25-034102.md) | [(20.7) d](/filings/0001437749-26-008411.md) | [(9.4)](/filings/0001437749-26-016116.md) | [(0.3) d](/filings/0001437749-26-026784.md) | [(6.5) d](/filings/0001437749-25-034102.md) | [(29.9) d](/filings/0001437749-26-008411.md) | [(25.4)](/filings/0001437749-26-016116.md) | [10.8 d](/filings/0001437749-26-026784.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [321](/filings/0001437749-24-015973.md) | [396](/filings/0001437749-25-010192.md) | [368](/filings/0001437749-26-008411.md) | [243](/filings/0001437749-26-008411.md) | [95.7](/filings/0001437749-26-008411.md) | | Gross margin | % | [7.3%](/filings/0001437749-24-015973.md) | [7.3%](/filings/0001437749-25-010192.md) | [11.1%](/filings/0001437749-26-008411.md) | [8.1%](/filings/0001437749-26-008411.md) | [(41.2%)](/filings/0001437749-26-008411.md) | | Operating margin | % | [4.0%](/filings/0001437749-24-015973.md) | [4.4%](/filings/0001437749-25-010192.md) | [7.4%](/filings/0001437749-26-008411.md) | [2.6%](/filings/0001437749-26-008411.md) | [(55.3%)](/filings/0001437749-26-008411.md) | | Net margin | % | [8.2%](/filings/0001437749-24-015973.md) | [3.8%](/filings/0001437749-25-010192.md) | [10.2%](/filings/0001437749-26-008411.md) | [6.4%](/filings/0001437749-26-008411.md) | [(51.6%)](/filings/0001437749-26-008411.md) | | Diluted EPS | $ per share | [0.60](/filings/0001437749-24-015973.md) | [0.35](/filings/0001437749-25-010192.md) | [0.85](/filings/0001437749-26-008411.md) | [0.35](/filings/0001437749-26-008411.md) | [(1.13)](/filings/0001437749-26-008411.md) | | Free cash flow | $m | [42.6](/filings/0001437749-24-015973.md) | [47.7](/filings/0001437749-25-010192.md) | [15.3](/filings/0001437749-26-008411.md) | [10.1](/filings/0001437749-26-008411.md) | [(46.0)](/filings/0001437749-26-008411.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ff/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $8.7m | 1,914,410 | | Added +82,521 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $6.5m | 1,433,400 | | Reduced −144,300 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $6.5m | 1,431,611 | | Reduced −258,493 | | [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $5.9m | 1,315,729 | | Added +1,208,276 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $5.2m | 1,141,243 | | Reduced −24,229 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $3.5m | 782,079 | | Reduced −45,996 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $3.0m | 660,893 | | Reduced −1,730 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.8m | 620,421 | | Reduced −915 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $2.4m | 540,985 | | Added +154,337 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $2.1m | 473,285 | | Reduced −5,129 | ## Recent filings [All 720 filings](/companies/ff/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-23 | 16:05 ET | [8-K](/filings/0001437749-26-031058.md) | 5.07 Shareholder vote results | 0001437749-26-031058 | | 2026-08-31 | 16:29 ET | [8-K](/filings/0001437749-26-029321.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-029321 | | 2026-08-12 | 16:23 ET | [DEF 14A](/filings/0001437749-26-027325.md) | Proxy statement, period 2026-09-22 | 0001437749-26-027325 | | 2026-08-10 | 16:27 ET | [10-Q](/filings/0001437749-26-026784.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026784 | | 2026-08-10 | 16:25 ET | [8-K](/filings/0001437749-26-026783.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-026783 | | 2026-07-28 | 16:17 ET | [8-K](/filings/0001437749-26-024674.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-024674 | | 2026-06-30 | 16:51 ET | [8-K](/filings/0001437749-26-022162.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-022162 | | 2026-06-26 | 16:32 ET | [8-K](/filings/0001437749-26-021846.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-021846 | | 2026-05-11 | 16:11 ET | [8-K](/filings/0001437749-26-016118.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016118 | | 2026-05-11 | 16:11 ET | [10-Q](/filings/0001437749-26-016116.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016116 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-008411.md), filed Mar 16, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/1c445354-4f33-4458-8a12-5828498e0b7f) ## About the filer - CIK: 1337298 - Tickers: FF - Exchange: NYSE - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:17 ET. No prices; not investment advice.